1. Simparica
1. 1398609-39-6
2. Simparica
3. Pf-6450567
4. Dm113ftw7f
5. 1-(5'-((5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'-h-spiro(azetidine-3,1'-(2)benzofuran)-1-yl)-2-(methylsulfonyl)ethanone
6. Ethanone, 1-(5'-((5s)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)spiro(azetidine-3,1'(3'h)-isobenzofuran)-1-yl)-2-(methylsulfonyl)-
7. (s)-1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'h-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethan-1-one
8. (s)-1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'h-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone
9. 1-[5'-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]spiro[azetidine-3,1'(3'h)-isobenzofuran]-1-yl]-2-(methylsulfonyl)ethanone
10. 1-[6-[(5s)-5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4h-1,2-oxazol-3-yl]spiro[1h-2-benzofuran-3,3'-azetidine]-1'-yl]-2-methylsulfonylethanone
11. Sarolaner [usan]
12. Sarolaner [usan:inn]
13. Unii-dm113ftw7f
14. Sarolaner [inn]
15. Sarolaner [mi]
16. Sarolaner (usan/inn)
17. Sarolaner(pf-6450567)
18. Sarolaner [green Book]
19. Chembl3137302
20. Schembl12097270
21. Dtxsid101336934
22. Ex-a5583
23. Sarolaner [ema Epar Veterinary]
24. Hy-16730
25. Stronghold Plus Component Sarolaner
26. Cs-0012328
27. Sarolaner Component Of Stronghold Plus
28. D10668
29. Q27276475
Molecular Weight | 581.4 g/mol |
---|---|
Molecular Formula | C23H18Cl2F4N2O5S |
XLogP3 | 3.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 580.0249609 g/mol |
Monoisotopic Mass | 580.0249609 g/mol |
Topological Polar Surface Area | 93.6 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 1050 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of tick infestations (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus). The veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.
For the treatment of flea infestations (Ctenocephalides felis and Ctenocephalides canis). The veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks. The veterinary medicinal product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
For the treatment of sarcoptic mange (Sarcoptes scabiei).
For the treatment of ear mite infestations (Otodectes cynotis).
For the treatment of demodicosis (Demodex canis).
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
QP53BE03
LOOKING FOR A SUPPLIER?